The inaugural successful application of CAR-T cell therapy — a homegrown cancer treatment — took place on an Indian patient recently. This highly expensive therapy can genetically reprogram the immune system of patients to combat cancer. The CDSCO granted commercial approval for CART-T cell therapy recently. It can treat acute lymphocytic leukaemia, multiple myeloma and hepatocellular carcinoma.